(13)Furthermore, Commission Implementing Regulation (EU) 2024/2692note amended the table set out in Part II of Annex VIII to Implementing Regulation (EU) 2021/620, by listing the Balearic Islands in Spain as a zone with an approved eradication programme for infection with BTV, with a date of initial approval of 21 February 2022. Implementing Regulation (EU) 2024/2692 entered into force on 21 October 2024. However, an error has now been detected in the date of initial approval as before 21 October 2024 the Balearic Islands had disease-free status with regard to infection with BTV and therefore was listed as such in Part I of Annex VIII to Implementing Regulation (EU) 2021/620. Consequently, the Balearic Islands did not have an approved eradication programme before 21 October 2024 and the date of their initial approval cannot be 21 February 2022. The entry for Spain in that table was later amended by Commission Implementing Regulations (EU) 2025/330note and (EU) 2025/1401note, with the same date of initial approval for the Balearic Islands. It is therefore appropriate to correct the date of 21 February 2022 and put the date of entry into force of Implementing Regulation (EU) 2024/2692 instead, namely 21 October 2024. Part II of Annex VIII should, therefore, be corrected accordingly.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.